Intervention to help surgical patients quit smoking
Evaluación de la Eficacia de Una intervención Para Dejar de Fumar en Pacientes prequirúrgicos de cirugía ortopédica o de cirugía General y urológica: Ensayo clínico Aleatorizado.
This study is testing a special program to help surgical patients quit smoking before their operations to see if it works better than just giving them basic advice.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 232 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospital Universitari Vall d'Hebron Research Institute Academic / other |
| Locations | 1 site (Barcelona, Catalunya) |
| Trial ID | NCT05961813 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of an intensive pre-surgical intervention designed to help patients quit smoking before undergoing orthopedic or general and urological surgeries. Participants will be randomly assigned to either an intensive intervention group, which includes multiple consultations with a preventive medicine specialist, or a control group that receives brief smoking cessation advice. The study will monitor participants through telephonic follow-ups at various intervals post-surgery to assess smoking habits and the overall efficacy of the intervention. Data collection and quality control will be conducted throughout the study to ensure accuracy and reliability.
Who should consider this trial
Good fit: Ideal candidates are adult smokers scheduled for surgery at least four weeks after enrollment in the study.
Not a fit: Patients who are pregnant, currently undergoing smoking cessation treatment, or unable to consent due to cognitive or language barriers may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve smoking cessation rates among surgical patients, leading to better surgical outcomes and overall health.
How similar studies have performed: Other studies have shown promising results with intensive smoking cessation interventions in surgical populations, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients must 18 years old or older, and be able to consent. * Surgery programmed for at least 4 weeks after inclusion in the study. * Smokers Exclusion Criteria: * Pregnancy * Already under treatment for smoking cessation * Inability to consent due to cognitive impairment or language barrier. * Non-primary knee or hip replacement surgery * Participation in any study that forbids use of nicotine substitution therapy (dermal, oral)
Where this trial is running
Barcelona, Catalunya
- Hospital Universitari Vall d'Hebron — Barcelona, Catalunya, Spain (Recruiting)
Study contacts
- Principal investigator: Eva Gavilán Castillo, RN; MSN — Vall d'Hebron Hospital
- Study coordinator: Eva Gavilán Castillo, RN; MSN
- Email: eva.gavilan@vallhebron.cat
- Phone: 934893000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.